Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Santo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
International Journal of Molecular Sciences|May 13, 2026
Phytochemistry-Guided Green Synthesis of Antimicrobial Silver Nanoparticles from <i>Cannabis sativa</i> ChemovarsFresia M Silva Sofrás, Sofia Municoy, Jimena Guajardo, et al.
Journal of Medical Entomology|December 25, 2016
Toxicological, Enzymatic, and Molecular Assessment of the Insecticide Susceptibility Profile of Triatoma infestans (Hemiptera: Reduviidae, Triatominae) Populations From Rural Communities of Santa Cruz, BoliviaPablo L Santo-Orihuela, Claudia V Vassena, Guillermo Carvajal, et al.
Molecules (Basel, Switzerland)|May 17, 2020
Surfactantless Emulsions Containing Eugenol for Imidacloprid Solubilization: Physicochemical Characterization and Toxicity against Insecticide-Resistant <i>Cimex lectularius</i>Mariano Cáceres, Eduardo Guzmán, Agustín Alvarez-Costa, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
IJU Case Reports|August 4, 2020
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acidKeitaro Watanabe, Suguru Shirotake, Yuta Umezawa, et al.
Reumatismo|April 2, 2019
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)G Carlino, M Fornaro, L Santo, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
International Journal of Molecular Sciences|May 13, 2026
Phytochemistry-Guided Green Synthesis of Antimicrobial Silver Nanoparticles from <i>Cannabis sativa</i> ChemovarsFresia M Silva Sofrás, Sofia Municoy, Jimena Guajardo, et al.
Journal of Medical Entomology|December 25, 2016
Toxicological, Enzymatic, and Molecular Assessment of the Insecticide Susceptibility Profile of Triatoma infestans (Hemiptera: Reduviidae, Triatominae) Populations From Rural Communities of Santa Cruz, BoliviaPablo L Santo-Orihuela, Claudia V Vassena, Guillermo Carvajal, et al.
Molecules (Basel, Switzerland)|May 17, 2020
Surfactantless Emulsions Containing Eugenol for Imidacloprid Solubilization: Physicochemical Characterization and Toxicity against Insecticide-Resistant <i>Cimex lectularius</i>Mariano Cáceres, Eduardo Guzmán, Agustín Alvarez-Costa, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
IJU Case Reports|August 4, 2020
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acidKeitaro Watanabe, Suguru Shirotake, Yuta Umezawa, et al.
Reumatismo|April 2, 2019
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)G Carlino, M Fornaro, L Santo, et al.
Leukemia|June 29, 2013
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKsD Cirstea, T Hideshima, L Santo, et al.
Pageof 5